Uterine Cervical Neoplasms
"Uterine Cervical Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the UTERINE CERVIX.
| Descriptor ID |
D002583
|
| MeSH Number(s) |
C04.588.945.418.948.850 C13.351.500.852.593.131 C13.351.500.852.762.850 C13.351.937.418.875.850
|
| Concept/Terms |
Uterine Cervical Neoplasms- Uterine Cervical Neoplasms
- Cervical Neoplasm, Uterine
- Cervical Neoplasms, Uterine
- Neoplasm, Uterine Cervical
- Neoplasms, Uterine Cervical
- Uterine Cervical Neoplasm
- Neoplasms, Cervical
- Cervical Neoplasms
- Cervical Neoplasm
- Neoplasm, Cervical
- Neoplasms, Cervix
- Cervix Neoplasms
- Cervix Neoplasm
- Neoplasm, Cervix
Cancer of the Uterine Cervix- Cancer of the Uterine Cervix
- Cancer of the Cervix
- Cervical Cancer
- Uterine Cervical Cancer
- Cancer, Uterine Cervical
- Cancers, Uterine Cervical
- Cervical Cancer, Uterine
- Cervical Cancers, Uterine
- Uterine Cervical Cancers
- Cancer of Cervix
- Cervix Cancer
- Cancer, Cervix
- Cancers, Cervix
|
Below are MeSH descriptors whose meaning is more general than "Uterine Cervical Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Uterine Cervical Neoplasms".
This graph shows the total number of publications written about "Uterine Cervical Neoplasms" by people in this website by year, and whether "Uterine Cervical Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 11 | 3 | 14 |
| 1995 | 15 | 1 | 16 |
| 1996 | 11 | 2 | 13 |
| 1997 | 14 | 5 | 19 |
| 1998 | 19 | 2 | 21 |
| 1999 | 20 | 3 | 23 |
| 2000 | 21 | 5 | 26 |
| 2001 | 14 | 1 | 15 |
| 2002 | 22 | 1 | 23 |
| 2003 | 24 | 2 | 26 |
| 2004 | 27 | 5 | 32 |
| 2005 | 49 | 2 | 51 |
| 2006 | 25 | 7 | 32 |
| 2007 | 36 | 2 | 38 |
| 2008 | 35 | 0 | 35 |
| 2009 | 22 | 3 | 25 |
| 2010 | 25 | 6 | 31 |
| 2011 | 26 | 5 | 31 |
| 2012 | 34 | 2 | 36 |
| 2013 | 35 | 3 | 38 |
| 2014 | 28 | 3 | 31 |
| 2015 | 39 | 6 | 45 |
| 2016 | 27 | 2 | 29 |
| 2017 | 23 | 8 | 31 |
| 2018 | 29 | 3 | 32 |
| 2019 | 40 | 4 | 44 |
| 2020 | 52 | 5 | 57 |
| 2021 | 39 | 0 | 39 |
| 2022 | 37 | 0 | 37 |
| 2023 | 57 | 0 | 57 |
| 2024 | 29 | 3 | 32 |
To return to the timeline,
click here.
Below are the most recent publications written about "Uterine Cervical Neoplasms" by people in Profiles.
-
Scaling cervical cancer screening in Mozambique: analysis of loop electrosurgical excision procedure (LEEP) specimens. Int J Gynecol Cancer. 2024 Nov 04; 34(11):1698-1703.
-
Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set up for the LASH trial. Int J Gynecol Cancer. 2024 Nov 04; 34(11):1805-1808.
-
Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study. Eur J Cancer. 2024 Nov; 211:114310.
-
Human Papillomavirus Vaccination and Human Papillomavirus-Related Cancer Rates. JAMA Netw Open. 2024 Sep 03; 7(9):e2431807.
-
In-clinic Versus Online Recruitment of Women With a History of Cervical Intraepithelial Neoplasia or Cervical Cancer to a Smoking Cessation Trial: A Post hoc Comparison of Participant Characteristics, Study Retention, and Cessation Outcomes. Nicotine Tob Res. 2024 Aug 22; 26(9):1264-1270.
-
Multiscale Optical Imaging Fusion for Cervical Precancer Diagnosis: Integrating Widefield Colposcopy and High-Resolution Endomicroscopy. IEEE Trans Biomed Eng. 2024 Sep; 71(9):2547-2556.
-
Understanding racial disparities in health care expenditures for cervical cancer. J Manag Care Spec Pharm. 2024 Aug; 30(8):873-881.
-
Neighborhood-level social determinants of health burden among adolescent and young adult cancer patients and impact on overall survival. JNCI Cancer Spectr. 2024 Jul 01; 8(4).
-
Immunotherapy in locally advanced cervix cancer: A critical appraisal of the FDA indication based on ENGOT-CX11/GOG-3047/KEYNOTE-A18. Gynecol Oncol. 2024 Sep; 188:81-82.
-
Immunotherapy in locally advanced cervical cancer: Integrating KEYNOTE-A18 into management strategies. Med. 2024 Jun 14; 5(6):487-489.